Evidence map›Paper›PMID 24319656›Full record

ArticleNeuroImage. Clinical2014

Pathomechanisms and compensatory efforts related to Parkinsonian speech.

Christiane Arnold, Johannes Gehrig, Suzana Gispert, Carola Seifried, Christian A Kell

Open access · goldAbstract read
In one paragraph

Article in NeuroImage. Clinical, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Speech treatment in Parkinson's disease: Randomized controlled trial (RCT).Movement disorders : official journal of the Movement Disorder Society · 2018
    Trial
  7. Article
  8. Article
  9. Article
  10. Applications of Artificial Intelligence in Neurological Voice Disorders.World journal of otorhinolaryngology - head and neck surgery · 2025
    Review
  11. Review
  12. Levodopa may modulate specific speech impairment in Parkinson's disease: an fMRI study.Journal of neural transmission (Vienna, Austria : 1996) · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Christiane ArnoldCognitive Neuroscience Group, Brain Imaging Center, Goethe University, Frankfurt, Germany ; Department of Neurology, Goethe University, Frankfurt, Germany.
Johannes Gehrig
Suzana Gispert
Carola Seifried
Christian A Kell
Goethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Voice and speech in Parkinson's disease (PD) patients are classically affected by a hypophonia, dysprosody, and dysarthria. The underlying pathomechanisms of these disabling symptoms are not well understood. To identify functional anomalies related to pathophysiology and compensation we compared speech-related brain activity and effective connectivity in early PD patients who did not yet develop voice or speech symptoms and matched controls. During fMRI 20 PD patients ON and OFF levodopa and 20 control participants read 75 sentences covertly, overtly with neutral, or with happy intonation. A cue-target reading paradigm allowed for dissociating task preparation from execution. We found pathologically reduced striato-prefrontal preparatory effective connectivity in early PD patients associated with subcortical (OFF state) or cortical (ON state) compensatory networks. While speaking, PD patients showed signs of diminished monitoring of external auditory feedback. During generation of affective prosody, a reduced functional coupling between the ventral and dorsal striatum was observed. Our results suggest three pathomechanisms affecting speech in PD: While diminished energization on the basis of striato-prefrontal hypo-connectivity together with dysfunctional self-monitoring mechanisms could underlie hypophonia, dysarthria may result from fading speech motor representations given that they are not sufficiently well updated by external auditory feedback. A pathological interplay between the limbic and sensorimotor striatum could interfere with affective modulation of speech routines, which affects emotional prosody generation. However, early PD patients show compensatory mechanisms that could help improve future speech therapies.

Indexed as

Biofeedback, PsychologyAgedAntiparkinson AgentsBrainFemaleHumansImage Processing, Computer-AssistedLevodopaLongitudinal StudiesMagnetic Resonance ImagingMaleMiddle AgedOxygenParkinson DiseasePsychoacousticsReadingAntiparkinson AgentsLevodopaOxygenAC, auditory cortexCN, caudate nucleusCOMT, catechol-O-methyltransferaseCON, control participantDAT1, dopamine transporterDLPFC, dorsolateral prefrontal cortexdPMC, dorsal premotor cortexdstriatum, dorsal striatumDysarthriaDysarthrophoniaEPI, echo-planar imagingfMRI, functional magnetic response imagingFunctional MRIFWE, family-wise errorGLM, general linear modelHRF, hemodynamic response functionHypophoniaIFG, inferior frontal gyrusLSVT, Lee Silverman Voice TreatmentmPFC, medial prefrontal cortexParkinson's diseasePD, Parkinson's diseasePPI, psycho-physiological interactionPUT, putamenROI, region of interestSEM, standard error of the meanSMA, supplementary motor areaSpeech productionSPL, superior parietal lobuleSTS, superior temporal sulcusSVC, small volume correctionT, TeslaUPDRS, Unified Parkinson's Disease Rating Scalevstriatum, ventral striatum

Identifiers

PMID24319656
PMCPMC3853351
OpenAlexW2095052125

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.